STEVEN C CORDERO
Allopathic & Osteopathic Physicians|Pathology|Anatomic Pathology & Clinical Pathology PINEHURST, NC NPI 1821259862
Browse related groups: Allopathic & Osteopathic Physicians|Pathology|Anatomic Pathology & Clinical Pathology NC Acerta Pharma LLC All categories
General Payments — all program years on this page
$61,792.82
- Category: General Payments
- Program years: PY2020–2024
- Record count: 26
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $14,676.32 across 5 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $14,661.13 | 4 |
| Food and Beverage | $15.19 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $14,661.13 | 4 |
| Roche Diagnostics Corporation | $15.19 | 1 |
By program year
Records — PY2024 (5)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089611148 | Roche Diagnostics Corporation | $15.19 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104470064 | AstraZeneca Pharmaceuticals LP | $4,295.25 | 09/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1104499148 | AstraZeneca Pharmaceuticals LP | $2,863.50 | 03/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1105746263 | AstraZeneca Pharmaceuticals LP | $2,024.38 | 12/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1105778000 | AstraZeneca Pharmaceuticals LP | $5,478.00 | 06/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.